MannKind
Presence
MannKind is one of the...
MannKind is a company listed under the stock ticker MNKD (US).
Executives
View the org chart displaying its 22 main executives
Most searched biographies at MannKind
- Michael Castagna, Chief Executive Officer and Director
- Michael Friedman, Director
- Kent Kresa, Director
Popular executive movements at MannKind
- Christopher Prentiss will join the company as Chief Financial Officer on Apr. 22, 2024 (posted on March 27 2024).
Create your alert
to follow the executive moves at MannKind.
Pharmaceuticals
MannKind has 1,861 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
Popular contacts in Pharmaceuticals
News
Press releases by MannKind
- MannKind Repays Certain Debt Obligations | MannKind Corporation
- MannKind Announces CFO Transition | MannKind Corporation
- MannKind Announces New Clinical Data From Inhale-3 Study to be Presented by Dr. Irl B. Hirsch at ATTD on March 8 | MannKind Corporation
- MannKind Corporation Announces Participation at Upcoming Conferences | MannKind Corporation
- INHALE-3 Study’s Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin Pumps | MannKind Corporation
- MannKind Corporation to Hold 2023 Fourth Quarter and Full Year Financial Results Conference Call on February 27, 2024 | MannKind Corporation
- MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development Update | MannKind Corporation
- MannKind Announces Enrollment Goal Completion of INHALE-1 Pediatric Diabetes Trial Utilizing Afrezza® | MannKind Corporation
- MannKind and Sagard Healthcare Enter Into Royalty Purchase Agreement for Up to $200 Million | MannKind Corporation
- MannKind Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference | MannKind Corporation
- View more press releases Close
Social media about MannKind
- MannKind on Wikipedia, Google News & Yahoo Finance
- MannKind on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Michael Castagna 
